Authors: Hentunen, TA Choi, SJ Boyce, BF Dallas, MR Dallas, SL Shen-Ong, GL Roodman, GD

Citation: Ta. Hentunen et al., A murine model of inflammatory bone disease, BONE, 26(2), 2000, pp. 183-188

Authors: Dallas, SL Keene, DR Bruder, SP Saharinen, J Sakai, LY Mundy, GR Bonewald, LF

Citation: Sl. Dallas et al., Role of the latent transforming growth factor beta binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo, J BONE MIN, 15(1), 2000, pp. 68-81

Authors: Oyajobi, BO Deng, JH Dallas, SL Jenson, HB Mundy, GR Gao, SJ

Citation: Bo. Oyajobi et al., Absence of herpesvirus DNA sequences in the 5T murine model of human multiple myeloma, BR J HAEM, 109(2), 2000, pp. 413-419

Authors: Michigami, T Shimizu, N Williams, PJ Niewolna, M Dallas, SL Mundy, GR Yoneda, T

Citation: T. Michigami et al., Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity, BLOOD, 96(5), 2000, pp. 1953-1960

Authors: Dallas, SL

Citation: Sl. Dallas, Measuring interactions between ECM and TGF beta-like proteins, METH MOL B, 139, 2000, pp. 231-243

Authors: Dallas, SL Garrett, IR Oyajobi, BO Dallas, MR Boyce, BF Bauss, F Radl, J Mundy, GR

Citation: Sl. Dallas et al., Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease, BLOOD, 93(5), 1999, pp. 1697-1706